|
| Figure 1: Top panel: Galectin-3 is highly expressed in the 44 pancreatic cancer cell lines in the CCLE. CDKN2A is included for reference. Bottom panel: An analysis of galectin-3 expression from microarray gene-expression profiles of 45 matching pairs of pancreatic tumor and adjacent non-tumor tissues from 45 patients with pancreatic ductal adenocarcinoma (PDAC) (GEO Series GSE28735). RMA = robust multi-array average (mRNA expression). |
See also the pancreatic cancer database for papers – here.
One thought on “Galectin-3 (LGALS3) upregulated in pancreatic cancer”